MCID: ESN011
MIFTS: 44

Eisenmenger Syndrome malady

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Eisenmenger Syndrome

About this section
Sources:
30ICD10 via Orphanet, 47NIH Rare Diseases, 49Novoseek, 53Orphanet, 67UMLS
See all MalaCards sources

Aliases & Descriptions for Eisenmenger Syndrome:

Name: Eisenmenger Syndrome 47 53 49
 
Eisenmenger Complex 67

Characteristics:

Orphanet epidemiological data:

53
eisenmenger syndrome:
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Belgium),1-9/1000000 (Europe); Age of onset: Adolescent,Adult,Childhood; Age of death: adult

Classifications:



External Ids:

Orphanet53 ORPHA97214
ICD10 via Orphanet30 I27.2

Summaries for Eisenmenger Syndrome

About this section
MalaCards based summary: Eisenmenger Syndrome, also known as eisenmenger complex, is related to angina pectoris and myocardial infarction. An important gene associated with Eisenmenger Syndrome is THBD (Thrombomodulin), and among its related pathways are NTHi-Induced Signaling and mTOR Pathway. Affiliated tissues include heart, lung and testes, and related mouse phenotypes are normal and embryo.

Related Diseases for Eisenmenger Syndrome

About this section

Diseases related to Eisenmenger Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 83)
idRelated DiseaseScoreTop Affiliating Genes
1angina pectoris29.4PLAT, THBD, VWF
2myocardial infarction27.7EDN1, PLAT, TGFB1, THBD, VWF
3mullerian aplasia10.5THBD, VWF
4psychologic dyspareunia10.4THBD, VWF
5parotid disease10.3EDN1, VWF
6celiac trunk compression syndrome10.3TGFBR1, TGFBR2
7pulmonary venous return anomaly10.3TGFBR1, TGFBR2
8chromophil adenoma of the kidney10.3TGFBR1, TGFBR2
9adenosine monophosphate deaminase deficiency erythrocyte type10.3TGFBR1, TGFBR2
10mesangioproliferative glomerulopathy10.3PLAT, THBD
11udd distal myopathy10.2TGFBR1, TGFBR2
12pulmonary hypertension10.2
13chronic diarrhea due to guanylate cyclase 2c overactivity10.2PLAT, VWF
14lymphatic system cancer10.2PLAT, THBD
15wfs1-related disorders10.2PLAT, VWF
16heart disease10.2
17ventricular septal defect10.2
18brucella canis brucellosis10.2TGFBR1, TGFBR2
19transvestism10.1BMPR2, EDN1
20colon carcinoma in situ10.1PLAT, VWF
21hepatitis c10.1EDN1, VIP
22parasitic protozoa infectious disease10.1PLAT, THBD
23tollner horst manzke syndrome10.1PLAT, THBD
24larynx carcinoma in situ10.1EDN1, VWF
25thrombocytosis10.0TGFB1, TGFBR3
26psychosexual disorder10.0PLAT, VWF
27fiedler's myocarditis10.0PLAT, THBD, VWF
28thrombophilia due to activated protein c resistance10.0PLAT, THBD, VWF
29microcytic anemia10.0PLAT, THBD, VWF
30calcifying epithelial odontogenic tumor10.0TGFB1, THBD
31ulcerative blepharitis10.0PLAT, THBD, VWF
32patent ductus arteriosus10.0
33pregnancy loss, recurrent 210.0PLAT, THBD, VWF
34littre gland carcinoma10.0PLAT, THBD, VWF
35intrinsic asthma10.0PLAT, TGFBR2
36stroke, ischemic10.0PLAT, THBD, VWF
37mediastinum seminoma9.9TGFBR1, TGFBR2
38endotheliitis9.9
39multiple epiphyseal dysplasia9.9BMPR2, TGFB1
40lipodystrophy, familial partial, type 69.8TGFB1, TGFBR1
41renal fibrosis9.8EDN1, PLAT, VWF
42adult respiratory distress syndrome9.8EDN1, PLAT, VWF
43tetralogy of fallot9.8
44down syndrome9.8
45vascular disease9.8
46aortopulmonary window9.8
47peripheral artery disease9.8EDN1, PLAT, VWF
48rheumatoid arthritis9.6
49coarctation of aorta9.6
50arthritis9.6

Graphical network of the top 20 diseases related to Eisenmenger Syndrome:



Diseases related to eisenmenger syndrome

Symptoms for Eisenmenger Syndrome

About this section

Drugs & Therapeutics for Eisenmenger Syndrome

About this section

Drugs for Eisenmenger Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Iloprostapproved, investigationalPhase 47778919-13-86443959
Synonyms:
(16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2)
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid
(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
(5Z)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
(E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(sup 2(1H),delta)-pentalenevaleric acid
(E)-5-(3aS,4R,5R,6aS)-5-Hydroxy-4((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-inyl)perhydropentalen-2-yliden)valeriansaeure
73873-87-7
78919-13-8
AC1NSK5T
AC1O5JIJ
AC1O5JP3
AC1Q1J28
ACT-213105
C22H32O4
CHEMBL138694
CHEMBL236025
CHEMBL494
CID10937300
CID11639089
CID5311181
CID6435293
CID6435378
CID9885245
 
CID9975807
Ciloprost
D02721
E-1030
Endoprost
HMS2090A19
ILOPROST
Ilomedin
Ilomedine
Iloprost
Iloprost (INN)
Iloprost [BAN:INN]
Iloprostum
Iloprostum [Latin]
L000996
LS-101845
NCGC00181784-01
PDSP2_001536
SH-401
UNII-JED5K35YGL
Ventavis
Ventavis (TN)
ZK 36374
ZK-36374
ZK-363775
[3H]-Iloprost
2
Bosentanapproved, investigationalPhase 4, Phase 3103147536-97-8104865
Synonyms:
-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
147536-97-8
174227-18-0
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide
4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
AC-148
AC1L2XN2
Actelion
Bosentan
Bosentan (INN)
Bosentan [USAN:INN:BAN]
Bosentan hydrate
C27H29N5O6S
CHEBI:51450
CHEMBL957
CID104865
D07538
DB00559
 
EN002863
HMS2090N14
I06-1873
KS-5062
L001086
LS-31532
MolPort-003-845-300
NCGC00167440-01
PDSP1_001731
PDSP2_001714
Ro 47-0203
Ro 47-0203/039
Ro-47-0203
Ro-47-0203/029
Ro-47-0203/039
TL8001039
Tracleer
UNII-XUL93R30K2
bosentan
bosentanum
bosentán
p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
p-tert-Butyl-N-[6-(2-hydroxyethoxy)
3Platelet Aggregation InhibitorsPhase 4, Phase 1, Phase 22419
4Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 13438
5Endothelin Receptor AntagonistsPhase 4, Phase 3215
6Antihypertensive AgentsPhase 4, Phase 34095
7
MacitentanapprovedPhase 333441798-33-0
Synonyms:
 
Macitentanum
8Sildenafil CitratePhase 3, Phase 1, Phase 2323171599-83-0
9Phosphodiesterase InhibitorsPhase 3, Phase 2, Phase 11254
10Phosphodiesterase 5 InhibitorsPhase 3, Phase 2, Phase 1571
11Endothelin A Receptor AntagonistsPhase 337
12CitrateNutraceuticalPhase 3, Phase 1, Phase 21106
13
Citric Acidnutraceutical, vet_approvedPhase 3, Phase 1, Phase 2110677-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
14
MilrinoneapprovedPhase 1, Phase 23478415-72-24197
Synonyms:
-bipyridine)-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-(3,4&prime
1,6-Dihydro-2-methyl-6-oxo-(3,4'-bipyridine)-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-3,4-bipyridine-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-[3,4'-bipyridine]-5-carbonitrile
111GE027
2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile
3-Cyano-6-methyl-5-(4-pyridyl)-2-pyridone
6-Methyl-5-(4-pyridyl)-2-pyridone-3-carbonitrile
6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile
78415-72-2
AB00514027
AC-4730
AC1L1HMP
AC1Q2EBX
BIDD:GT0197
BPBio1_001156
BRN 3546821
BSPBio_001050
C07224
C12H9N3O
CAS-78415-72-2
CCRIS 3795
CHEBI:50693
CHEMBL189
CID4197
CPD000058475
Corotrop
Corotrope
D00417
DB00235
EINECS 278-903-6
EN002063
EU-0100737
HMS1571E12
HMS2051L10
HMS2090J14
I06-0259
LS-44610
Lopac-M-4659
Lopac0_000737
 
M 4659
M1663
M4659_SIGMA
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
MLS000028818
MLS001424052
Milrila
Milrila (TN)
Milrinona
Milrinona [Spanish]
Milrinone
Milrinone (JAN/USAN/INN)
Milrinone Lactate
Milrinone [USAN:BAN:INN]
Milrinonum
Milrinonum [Latin]
NCGC00015675-01
NCGC00015675-02
NCGC00015675-04
NCGC00015675-07
NCGC00025189-01
NCGC00025189-02
NCGC00025189-03
NCGC00164390-01
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Prestwick0_001065
Prestwick1_001065
Prestwick2_001065
Prestwick3_001065
Primacor
S2484_Selleck
SAM001246611
SBB055743
SMR000058475
SPBio_002965
Tocris-1504
UNII-JU9YAX04C7
WIN 47203-2
Win-47203
Win-47203-2
YM 018
ZINC09224016
milrinone
15
Tadalafilapproved, investigationalPhase 2149171596-29-5110635
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
ADCIRCA
Acdirca
Adcirca
C429886
CHEBI:41488
CHEMBL779
CID110635
CPD000466321
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
D02008
DB00820
FT-0080116
GF 196960
GF-196960
 
HMS2051N17
HSDB 7303
IC 351
IC-351
ICOS 351
Ic351
KS-1117
LS-186558
LS-187015
LS-187770
Lilly brand of tadalafil
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadanafil
UNII-742SXX0ICT
ZINC03993855
16Protective AgentsPhase 1, Phase 27190
17Phosphodiesterase 3 InhibitorsPhase 1, Phase 2131
18
Treprostinilapproved, investigational8581846-19-754786, 6918140
Synonyms:
((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate
(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid
({(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl}oxy)acetic acid
15 AU81
15AU81
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
289480-64-4 (Sodium salt)
81846-19-7
AC1L1HPX
AC1OCF2J
CHEBI:50861
CID11246284
CID54786
CID6918140
CID9800580
D06213
DB00374
L001079
 
LRX 15
LS-177654
LS-187014
LS-187645
Remodulin (TN)
Treprostinil
Treprostinil (USAN/INN)
Treprostinil [USAN:INN]
Treprostinil sodium
Treprostinilo
Treprostinilum
U 62840
U-62,840
UNII-RUM6K67ESG
UT-15
Uniprost
Viveta
[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid
treprostinilo
treprostinilum
19Selexipagapproved14475086-01-2
20
Epoprostenolapproved5361849-14-7, 35121-78-95280427, 5282411
Synonyms:
(5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
136626-78-3
35121-78-9
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[5-hydroxy-4-(3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
61849-14-7
63748-50-5
63859-31-4
AC1L18LX
AC1L3FZB
AC1NQX0K
AC1NR00P
AC1O51WG
AC1O5HI7
AR-1I7150
BIDD:GT0514
BRD-K64054020-001-02-7
BRN 1690090
BSPBio_001496
Bio2_000216
Bio2_000696
C01312
CHEBI:15552
CHEMBL1139
CHEMBL307845
CID114805
CID11969614
CID159
CID5280427
CID5282411
CID6434194
CID6450541
 
CID9864371
CID9975312
D00106
DB01240
Epoprostanol
Epoprostenol
Epoprostenol (TN)
Epoprostenol (USAN/INN)
Epoprostenol [USAN:INN]
Epoprostenolum
Epoprostenolum [INN-Latin]
Flolan
HMS1791K18
HMS1989K18
IDI1_033966
KB-IV-24
KBio2_000216
KBio2_002784
KBio2_005352
KBio3_000431
KBio3_000432
KBioGR_000216
KBioSS_000216
LMFA03010087
LS-125828
NCGC00161285-01
NCGC00161285-02
NCGC00161285-03
PDSP1_001721
PDSP2_001704
PG-I2
PGI(sub 2)
PGI2
PGX
Prostacyclin
Prostacyclin I2
Prostacycline
Prostacyclins
Prostaglandin I
Prostaglandin I(2)
Prostaglandin I2
Prostaglandin X
Prostaglandin x
Prostaglandins X
SMP2_000227
TRY 200
Try-200
U 53,217
U-53217
UNII-DCR9Z582X0
Vasocyclin
epoprostenol
prostacyclin
prostaglandin I2
21
Ironapproved11237439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
22
Allopurinolapproved137315-30-02094
Synonyms:
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one
184856-42-6
1H-Pyrazolo(3,4-D)pyrimidin-4-ol
22767-92-6
315-30-0
39464-14-7
4'-Hydroxypyrazolol(3,4-D)pyrimidine
4-HPP
4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-Hydroxypyrazolo(3,4-D)pyrimidine
4-Hydroxypyrazolopyrimidine
4-Hydroxypyrazolyl(3,4-D)pyrimidine
4H-Pyrazolo(3,4-D)pyrimidin-4-one
7HP
A 8003
A0907
A8003_SIGMA
AC-019
AC1L1CWL
AC1Q6FWV
AC1Q6GP7
AKOS000267490
AKOS000269759
AL-100
Adenock
Ailural
Ailurial
Allo-Puren
Allohexal
Allohexan
Alloprin
Allopur
Allopurin
Allopurinol
Allopurinol Sodium
Allopurinol(I)
Allopurinolum
Allopurinolum [INN-Latin]
Allorin
Allozym
Allpargin
Allural
Aloprim
Alopurinol
Alopurinol [INN-Spanish]
Aloral
Alositol
Aluline
Anoprolin
Anzief
Apo-Allopurinol
Apulonga
Apurin
Apurol
Atisuril
B. W. 56-158
BB_SC-5394
BIM-0061756.0001
BSPBio_001798
BW 56-158
BW 56158
BW-56-158
Bio-0799
Bleminol
Bloxanth
C5H4N4O
CCRIS 626
CHEBI:40279
CHEBI:495607
CHEMBL1467
CID2094
CPD-9024
CPD000059083
Caplenal
Capurate
Cellidrin
Cosuric
D000493
DB00437
Dabrosin
Dabroson
DivK1c_000685
Dura Al
EINECS 206-250-9
EN000932
EU-0100102
Embarin
Epidropal
Epuric
Foligan
Geapur
Gichtex
Gotax
HMS1920A15
HMS2091G15
HMS502C07
HPP
 
HSDB 3004
Hamarin
Hexanuret
I03-0052
IDI1_000685
Jenapurinol
Jsp005881
KBio1_000685
KBio2_000386
KBio2_002954
KBio2_005522
KBio3_001298
KBioGR_000550
KBioSS_000386
Ketanrift
Ketobun-A
LS-1180
Ledopur
Lopac-A-8003
Lopac0_000102
Lopurin
Lysuron
MLS000069453
MLS001148183
Milurit
Milurite
Miniplanor
MolPort-000-141-383
MolPort-000-870-337
MolPort-004-758-159
MolPort-004-758-166
MolPort-004-758-167
MolPort-004-758-643
Monarch
NCGC00015094-01
NCGC00015094-03
NCGC00015094-06
NCGC00091134-01
NCGC00091134-02
NCGC00091134-03
NCGC00094580-01
NCGC00094580-02
NCIOpen2_001825
NINDS_000685
NSC 101655
NSC 1390
NSC-1390
NSC101655
NSC1390
Nektrohan
Novopurol
Pan Quimica
Prestwick_511
Progout
Pureduct
Purinol
Quimica, Pan
Remid
Riball
Rimapurinol
Roucol
S1630_Selleck
SAM002554884
SMR000059083
SPBio_000056
SPECTRUM1500108
STK378584
STK711106
Sigapurol
Spectrum2_000098
Spectrum3_000289
Spectrum4_000135
Spectrum5_000768
Spectrum_000026
Suspendol
Takanarumin
Tipuric
UNII-63CZ7GJN5I
Urbol
Uribenz
Uricemil
Uridocid
Uriprim
Uripurinol
Uritas
Urobenyl
Urolit
Urosin
Urtias
Urtias 100
Xanthomax
Xanturat
Xanturic
Zygout
Zyloprim
Zyloprim (tn)
Zyloric
allopurinol
nchembio.92-comp3
nchembio732-comp4
23Imatinib Mesylate594123596
24Vaccines6428
25diuretics1372
26Anticoagulants2516
27Anti-Bacterial Agents10884
28Antibiotics, Antitubercular6972
29Angiotensin-Converting Enzyme Inhibitors711
30Tezosentan65

Interventional clinical trials:

(show all 22)
idNameStatusNCT IDPhase
1Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart DiseaseUnknown statusNCT01383083Phase 4
2Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyCompletedNCT00317486Phase 4
3BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyCompletedNCT00367770Phase 4
4Bosentan in Treatment of Pulmonary Arterial HypertensionCompletedNCT00266162Phase 4
5Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers SyndromeCompletedNCT00303004Phase 3
6Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger SyndromeCompletedNCT01743001Phase 3
7Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger SyndromeActive, not recruitingNCT01739400Phase 3
8Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger PatientsTerminatedNCT00586794Phase 3
9Phosphodiesterase-5 Inhibitor in Eisenmenger SyndromeCompletedNCT01200732Phase 2
10Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary HypertensionCompletedNCT02595541Phase 1, Phase 2
11Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart DefectsRecruitingNCT01397110Phase 2
12Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline MalateUnknown statusNCT01683981Early Phase 1
13The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger SyndromeCompletedNCT01283958
14Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger SyndromeCompletedNCT02661802
15Sleep-disordered Breathing in Eisenmenger SyndromeCompletedNCT02614417
16Eisenmenger's Syndrome in Adults With CHDCompletedNCT00266903
17Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger SyndromeRecruitingNCT02752399
18Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart ValvesRecruitingNCT02119442
19COMPERA / COMPERA-KIDSRecruitingNCT01347216
20Eisenmenger Quality Enhancement Research InitiativeActive, not recruitingNCT01623492
21Eisenmenger Syndrome in the Nordic CountriesActive, not recruitingNCT01976533
22Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseTerminatedNCT01319045

Search NIH Clinical Center for Eisenmenger Syndrome

Genetic Tests for Eisenmenger Syndrome

About this section

Anatomical Context for Eisenmenger Syndrome

About this section

MalaCards organs/tissues related to Eisenmenger Syndrome:

35
Heart, Lung, Testes, Brain, Endothelial, Breast

Animal Models for Eisenmenger Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Eisenmenger Syndrome:

40 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00028738.7BMPR2, EDN1, TGFBR1, TGFBR2, THBD, VIP
2MP:00053808.3BMPR2, EDN1, TGFB1, TGFBR1, TGFBR2, THBD
3MP:00053817.9EDN1, PLAT, TGFB1, TGFBR1, TGFBR2, THBD
4MP:00053887.7BMPR2, PLAT, TGFB1, TGFBR1, TGFBR2, THBD
5MP:00053697.6BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2
6MP:00053847.6BMPR2, PLAT, TGFB1, TGFBR1, TGFBR2, TGFBR3
7MP:00053977.6BMPR2, PLAT, TGFB1, TGFBR1, TGFBR2, TGFBR3
8MP:00036317.3BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2
9MP:00053877.1BMPR2, PLAT, TGFB1, TGFBR1, TGFBR2, TGFBR3
10MP:00053767.0BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2
11MP:00053906.8BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2
12MP:00053856.7BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2
13MP:00107686.6BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2

Publications for Eisenmenger Syndrome

About this section

Articles related to Eisenmenger Syndrome:

(show top 50)    (show all 258)
idTitleAuthorsYear
1
Brain metabolite alterations in Eisenmenger syndrome: Evaluation with MR proton spectroscopy. (28027769)
2017
2
Effects of acute oxygen supplementation on functional capacity and heart rate recovery in Eisenmenger syndrome. (28082094)
2017
3
OS 12-06 EFFECT OF LONG-TERM ILOPROST TREATMENT ON THE RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH EISENMENGER SYNDROME. (27753979)
2016
4
Clinical and Prognostic Value of Depressive Symptoms and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Eisenmenger Syndrome. (26355727)
2015
5
Pulmonary arterial wall thickness in Eisenmenger Syndrome: Prospective, cross-sectional, controlled clinical trial. (26110269)
2015
6
Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome. (26471823)
2015
7
The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. (24275297)
2014
8
Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography. (24682249)
2014
9
Treat-and-Repair Approach to Eisenmenger Syndrome. (24869498)
2014
10
Inflammatory markers are elevated in Eisenmenger syndrome. (23666048)
2013
11
Red blood cell distribution width predicts survival in patients with Eisenmenger syndrome. (24317786)
2013
12
Patent ductus arteriosus with Eisenmenger syndrome. (23583537)
2013
13
Paracardiac mass on chest X-ray in a patient with Eisenmenger syndrome. (23102605)
2013
14
Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus. (24293472)
2013
15
Recurrent gastrointestinal bleeding in a patient with Eisenmenger syndrome using bosentan. (24102362)
2013
16
Eisenmenger syndrome complicated by pulmonary artery dissection. (22215497)
2012
17
Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study. (21914136)
2011
18
The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options. (22043211)
2010
19
Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. (20202971)
2010
20
The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results. (22043212)
2010
21
Pseudohypoglycemia in a patient with the Eisenmenger syndrome. (20231583)
2010
22
Down patients with Eisenmenger syndrome: is bosentan treatment an option? (18579234)
2009
23
Eisenmenger syndrome--a unique form of pulmonary arterial hypertension. (20196469)
2009
24
Clinical and hemodynamic picture of Eisenmenger syndrome. (20196474)
2009
25
Eisenmenger syndrome: A clinical review. (19541542)
2009
26
Eisenmenger syndrome: identifying the clues for arrhythmia. (18258531)
2008
27
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. (18519847)
2008
28
Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology? (17467397)
2007
29
Compression of the left main coronary artery by the pulmonary artery in a patient with the Eisenmenger syndrome. (17311829)
2007
30
Eisenmenger syndrome: towards identifying the risk factors for death. (16793920)
2006
31
Long-term behavior of endothelial and coagulation markers in Eisenmenger syndrome. (16708119)
2006
32
Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome. (16164790)
2005
33
Eisenmenger syndrome: medical prevention and management strategies. (16197358)
2005
34
Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. (12860221)
2003
35
Eisenmenger syndrome: a case study. (11244669)
2001
36
Bilateral central retinal vein occlusion in Eisenmenger syndrome. (11476697)
2001
37
Eisenmenger syndrome in pregnancy. (11013476)
2000
38
Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. (10862589)
2000
39
Noncardiac surgery in Eisenmenger syndrome. (9935034)
1999
40
How to manage the Eisenmenger syndrome. (9482138)
1998
41
Images in cardiovascular medicine. Huge dilatation of pulmonary arteries due To ventricular septal defect with the Eisenmenger syndrome. (8941151)
1996
42
Successful pulmonary resection after spontaneous hemopneumothorax in the Eisenmenger syndrome. (1877044)
1991
43
Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect. (1841020)
1991
44
The anaesthetic management of the Eisenmenger syndrome. (4004057)
1985
45
The anaesthetic management of the Eisenmenger syndrome. (6385803)
1984
46
Eisenmenger syndrome--a clinical and haemodynamic study. (7169456)
1982
47
Eisenmenger syndrome in pregnancy: a possible cause of neonatal polycythemia and persistent fetal circulation. (7145258)
1982
48
Prevention of the Eisenmenger syndrome; observations in surgical survivors. (619520)
1978
49
Presentation and natural history of Eisenmenger syndrome. (5557481)
1971
50
The Eisenmenger syndrome. (6020789)
1967

Variations for Eisenmenger Syndrome

About this section

Expression for genes affiliated with Eisenmenger Syndrome

About this section
Search GEO for disease gene expression data for Eisenmenger Syndrome.

Pathways for genes affiliated with Eisenmenger Syndrome

About this section

Pathways related to Eisenmenger Syndrome according to GeneCards Suite gene sharing:

(show all 35)
idSuper pathwaysScoreTop Affiliating Genes
19.6TGFBR1, TGFBR2
2
Show member pathways
9.2TGFBR1, TGFBR2, TGFBR3
3
Show member pathways
9.2PLAT, THBD, VWF
4
Show member pathways
9.2PLAT, THBD, VWF
59.1BMPR2, TGFBR1, TGFBR2
6
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
78.8TGFB1, TGFBR1, TGFBR2
8
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
98.8TGFB1, TGFBR1, TGFBR2
108.8TGFB1, TGFBR1, TGFBR2
11
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
128.8TGFB1, TGFBR1, TGFBR2
13
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
14
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
15
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
16
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
178.8TGFB1, TGFBR1, TGFBR2
18
Show member pathways
8.8TGFB1, TGFBR1, TGFBR2
19
Show member pathways
8.6TGFB1, TGFBR1, TGFBR3, VWF
208.5BMPR2, TGFB1, TGFBR1, TGFBR3
21
Show member pathways
8.4TGFB1, TGFBR1, TGFBR2, TGFBR3
228.4TGFB1, TGFBR1, TGFBR2, TGFBR3
238.4TGFB1, TGFBR1, TGFBR2, TGFBR3
248.4TGFB1, TGFBR1, TGFBR2, TGFBR3
25
Show member pathways
8.4TGFB1, TGFBR1, TGFBR2, TGFBR3
268.4TGFB1, TGFBR1, TGFBR2, TGFBR3
278.4TGFB1, TGFBR1, TGFBR2, TGFBR3
28
Show member pathways
8.3BMPR2, TGFB1, TGFBR1, TGFBR2
29
Show member pathways
8.3BMPR2, TGFB1, TGFBR1, TGFBR2
308.3BMPR2, TGFB1, TGFBR1, TGFBR2
31
Show member pathways
8.0BMPR2, TGFB1, TGFBR1, TGFBR2, TGFBR3
327.9EDN1, TGFB1, TGFBR1, TGFBR2, THBD
33
Show member pathways
7.9EDN1, TGFB1, TGFBR1, TGFBR2, TGFBR3
347.8PLAT, TGFB1, TGFBR1, TGFBR2, TGFBR3
35
Show member pathways
6.4BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2

GO Terms for genes affiliated with Eisenmenger Syndrome

About this section

Cellular components related to Eisenmenger Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Weibel-Palade bodyGO:003309310.3EDN1, VWF
2transforming growth factor beta receptor homodimeric complexGO:007002210.1TGFBR1, TGFBR2
3receptor complexGO:00432359.7TGFBR1, TGFBR2, TGFBR3
4extracellular spaceGO:00056157.4BMPR2, EDN1, PLAT, TGFB1, TGFBR3, THBD
5cell surfaceGO:00099866.7BMPR2, PLAT, TGFB1, TGFBR1, TGFBR2, TGFBR3

Biological processes related to Eisenmenger Syndrome according to GeneCards Suite gene sharing:

(show all 42)
idNameGO IDScoreTop Affiliating Genes
1cardiac epithelial to mesenchymal transitionGO:006031710.4TGFBR1, TGFBR3
2activin receptor signaling pathwayGO:003292410.3BMPR2, TGFBR1
3regulation of protein bindingGO:004339310.3TGFBR1, TGFBR3
4negative regulation of blood coagulationGO:003019510.3EDN1, THBD
5positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formationGO:190500710.3TGFBR1, TGFBR2
6body fluid secretionGO:000758910.2EDN1, VIP
7ventricular septum morphogenesisGO:006041210.2TGFBR1, TGFBR2
8regulation of sensory perception of painGO:005193010.1EDN1, VIP
9peptidyl-threonine phosphorylationGO:001810710.0TGFBR1, TGFBR2
10embryonic cranial skeleton morphogenesisGO:004870110.0TGFBR1, TGFBR2
11lens development in camera-type eyeGO:000208810.0TGFBR1, TGFBR2
12positive regulation of bone mineralizationGO:00305019.8BMPR2, TGFB1
13positive regulation of epithelial cell migrationGO:00106349.8BMPR2, TGFBR2
14positive regulation of SMAD protein import into nucleusGO:00603919.8TGFB1, TGFBR1
15common-partner SMAD protein phosphorylationGO:00071829.8TGFB1, TGFBR2
16signal transduction by protein phosphorylationGO:00230149.8BMPR2, TGFBR1, TGFBR2
17response to immobilization stressGO:00359029.8TGFB1, VWF
18positive regulation of odontogenesisGO:00424829.8EDN1, TGFB1
19positive regulation of endothelial cell proliferationGO:00019389.8BMPR2, TGFBR1, VIP
20germ cell migrationGO:00083549.7TGFB1, TGFBR1
21palate developmentGO:00600219.6TGFBR1, TGFBR2, TGFBR3
22in utero embryonic developmentGO:00017019.6EDN1, TGFBR1, TGFBR2
23myeloid dendritic cell differentiationGO:00430119.5TGFB1, TGFBR2
24blood coagulationGO:00075969.5PLAT, THBD, VWF
25epithelial to mesenchymal transitionGO:00018379.4TGFB1, TGFBR1, TGFBR3
26response to cholesterolGO:00707239.4TGFB1, TGFBR1, TGFBR2
27positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.3BMPR2, TGFB1, TGFBR1
28cellular response to transforming growth factor beta stimulusGO:00715609.3EDN1, TGFB1, TGFBR1
29animal organ regenerationGO:00311009.3TGFB1, TGFBR2, TGFBR3
30heart developmentGO:00075079.3EDN1, TGFBR1, TGFBR2
31positive regulation of epithelial to mesenchymal transitionGO:00107189.2TGFB1, TGFBR1, TGFBR2
32cell growthGO:00160499.2EDN1, TGFB1, TGFBR3
33pathway-restricted SMAD protein phosphorylationGO:00603899.1TGFB1, TGFBR1, TGFBR2, TGFBR3
34wound healingGO:00420609.0TGFB1, TGFBR1, TGFBR2
35transforming growth factor beta receptor signaling pathwayGO:00071799.0TGFB1, TGFBR1, TGFBR2, TGFBR3
36regulation of cell proliferationGO:00421279.0BMPR2, TGFB1, TGFBR2
37negative regulation of transforming growth factor beta receptor signaling pathwayGO:00305128.8TGFB1, TGFBR1, TGFBR2, TGFBR3
38regulation of gene expressionGO:00104688.8TGFB1, TGFBR1, TGFBR2
39protein phosphorylationGO:00064688.7BMPR2, TGFB1, TGFBR1, TGFBR2
40positive regulation of cell migrationGO:00303358.7EDN1, TGFB1, TGFBR1
41positive regulation of cell proliferationGO:00082847.8EDN1, TGFB1, TGFBR1, TGFBR2, VIP
42response to hypoxiaGO:00016667.3EDN1, PLAT, TGFB1, TGFBR2, TGFBR3

Molecular functions related to Eisenmenger Syndrome according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1growth factor bindingGO:001983810.3BMPR2, TGFBR1
2transmembrane receptor protein serine/threonine kinase activityGO:000467510.2BMPR2, TGFBR2
3glycosaminoglycan bindingGO:000553910.2TGFBR2, TGFBR3
4transforming growth factor beta-activated receptor activityGO:000502410.0TGFBR1, TGFBR2, TGFBR3
5transforming growth factor beta bindingGO:00504319.9TGFBR1, TGFBR2, TGFBR3
6type I transforming growth factor beta receptor bindingGO:00347139.9TGFB1, TGFBR2
7SMAD bindingGO:00463329.8TGFBR1, TGFBR2, TGFBR3
8type II transforming growth factor beta receptor bindingGO:00051149.7TGFB1, TGFBR1, TGFBR3
9glycoprotein bindingGO:00019489.2PLAT, TGFB1, VWF
10protein bindingGO:00055155.8BMPR2, EDN1, PLAT, TGFB1, TGFBR1, TGFBR2

Sources for Eisenmenger Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet